Market share of major varicella vaccine manufacturers in China 2019

In 2019, China National Pharmaceutical Group (Sinopharm) was the largest varicella (chickenpox) vaccine manufacturer in China, accounting for 39 percent of the total lot released volume. Measles, mumps and rubella are common respiratory infectious diseases among children. As varicella vaccine was not included into the category one, which is managed by the Chinese government and free-of-charge, the coverage rate of varicella vaccine in China was relatively lower than in other developed countries.

Market share of major varicella vaccine manufacturers in China in 2019, based on lot release volume

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

June 2020

Region

China

Survey time period

2019

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Vaccine industry in China"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.